10/5/2026
AdvisorShares Trust holds 6.78% stake in Psyence Biomedical
The investment firm reports significant ownership in Psyence Biomedical as of September 2026.
Topic archive
ontario
5 stories
9/23/2026
NeuroThera expands U.S. patent portfolio with Clearmind
New patent applications cover LSD, ketamine, and ibogaine combinations for mental health.
9/10/2026
Filament Health plans stability program for ibogaine drug
IBEX011 stability program aims to meet growing demand for standardized ibogaine.
8/5/2026
Ibogaine healing experience linked to sudden death in Ontario
Police in Cambridge, Ontario, investigate death after ibogaine use.
7/15/2026
Royal Ontario Museum hosts psychedelics exhibit
Exhibit explores the evolving role of psychedelics in culture and medicine.